| Name | Title | Contact Details |
|---|
The American Journal of Pharmacy Benefits is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Humedica, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Brighton, MA. To find more information about Humedica, Inc., please visit www.humedica.com
"With corporate headquarters in Los Gatos, BaySport, Inc. has been serving the Bay Area since 1984. The organization has evolved from providing ""on-site"" physical examination programs for corporations, to developing sports medicine centers with a strong"
Apricus Biosciences Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Apricus Biosciences Inc., please visit www.apricusbio.com